ThermoGenesis Holdings, Inc.

THMO

US88362L2097

Office Equipment

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.68 ^USD	0.00%		+2.63%	+13.14%

Apr. 16	ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 10	North American Morning Briefing : Traders Await -2-	DJ

ThermoGenesis Holdings, Inc. acquired CDMO facility.

March 29, 2023

ThermoGenesis Holdings, Inc. (NasdaqCM:THMO) acquired CDMO facility in April, 2022.

ThermoGenesis Holdings, Inc. (NasdaqCM:THMO) completed the acquisition of CDMO facility in April, 2022.

Latest news about ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
North American Morning Briefing : Traders Await -2-	Apr. 10	DJ
North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ
Thermogenesis Holdings, Inc. Announces Resignation of Haihong Zhu, Chief Operating Officer and A Director from the Board	Mar. 12	CI
ThermoGenesis Files $30 Million Mixed Shelf	Nov. 24	MT
Transcript : ThermoGenesis Holdings, Inc., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
ThermoGenesis Holdings, Inc. to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento	23-10-26	CI
ThermoGenesis Holdings, Inc. Announces Management Changes	23-08-29	CI
Transcript : ThermoGenesis Holdings, Inc., Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
ThermoGenesis Holdings, Inc. announced that it has received $1 million in funding	23-07-30	CI
ThermoGenesis Holdings, Inc. Announces Board Appointments	23-07-19	CI
Top Premarket Gainers	23-06-06	MT
North American Morning Briefing : Retail Sales, -2-	23-05-16	DJ
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Transcript : ThermoGenesis Holdings, Inc., Q1 2023 Earnings Call, May 15, 2023	23-05-15
ThermoGenesis Files Shelf for Up to 3 Million Common Shares on Behalf of Selling Stockholder	23-04-19	MT
ThermoGenesis Holdings Files Shelf on Behalf of Selling Stockholder	23-04-05	MT
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Transcript : ThermoGenesis Holdings, Inc., Q4 2022 Earnings Call, Mar 30, 2023	23-03-30
ThermoGenesis Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
ThermoGenesis Holdings, Inc. acquired CDMO facility.	23-03-29	CI
ThermoGenesis Holdings Closes $3 Million Private Placement	23-03-21	MT
ThermoGenesis Holdings, Inc. announced that it has received $2.999907 million in funding	23-03-19	CI

Chart ThermoGenesis Holdings, Inc.

Duration

Period

More charts

ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.

Sector

Office Equipment

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ThermoGenesis Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.68 USD

Average target price

5 USD

Spread / Average Target

+635.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
THERMOGENESIS HOLDINGS, INC.	+13.14%	5.41M
SHIMADZU CORPORATION	+7.13%	7.91B
TECAN GROUP AG	-3.15%	4.66B
OLINK HOLDING AB	-9.18%	2.84B
JEOL LTD.	+1.11%	2.03B
NINGBO YONGXIN OPTICS CO.,LTD	-26.56%	1.12B
FOCUSED PHOTONICS (HANGZHOU), INC.	-22.71%	759M
PARK SYSTEMS CORP.	-13.49%	755M
MLOPTIC CORP.	-56.85%	682M
PHENIX OPTICAL COMPANY LIMITED	-24.66%	671M

Scientific & Precision Equipment